Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-041214

President & Immunovant CEO sold 200,000 shares at $20.22 ($4,044,000)

  • President & Immunovant CEO acquired 200,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2025-11-07 Option exercise 10b5-1 +200,000 $3.85 $770,000 1,704,959 D: show line 1 in the form
Venker Eric President & Immunovant CEO 2025-11-07 Sale 10b5-1 −200,000 $20.22 $4,044,000 1,504,959 D: show line 2 in the form
Open-market sales · 200,000 sh · avg $20.22 · $4,044,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Venker Eric President & Immunovant CEO 2025-11-07 Option exercise · Stock Option (Right to Buy) 10b5-1 −200,000 $20.22 $4,044,000 6,076,523 D: show line 3 in the form
Loading xslF345X05/form4.xml…